Great Lakes Neuro Technologies received an allowance of patent claims from the U.S Patent Office for their “Movement Disorder Monitoring System and Method”. This system is able to make quantitative assessments of motor symptoms associated with movement disorders. When used for telemedicine applications, physicians will be able to use a web interface to track symptom responses and fluctuations.
The system uses wireless patient-worn motion sensors to assess tremor, bradykinesia, rigidity, and dyskinesias associated with diseases like Parkinson’s and essential tremor. This medical technology has applications for both in-clinic and home-based patient care, optimizing programming for deep brain stimulation, and to provide quantitative endpoints to determine the efficacy of clinical trials.
“The allowance of our patent claims continues a successful commercialization path for our Parkinson’s assessment systems intended to help physicians maximize therapeutic benefits and ultimately improve patient quality of life,” says Joseph P. Giuffrida, PhD, President of Great Lakes Neuro Technologies.
The company has been actively involved in developing and manufacturing technologies to standardize, automate, and remotely capture patient assessments in the movement disorders market. The National Institute of Neurological Disorders and Stroke and the National Institute on Aging have provided continued support for these technologies.
The company is continuing to build their intellectual property portfolio and is covering new applications arising from several on-going clinical studies. “We have a broad range of patent applications in the pipeline and expect this to be the first patent of many to cover our product base for movement disorder technologies,” says Brian Kolkowski, PhD, Executive Vice President and General Counsel. “In addition, this U.S. patent represents a first step as we plan to continue with international filings to protect our technology portfolio to support our growth in international markets”
The company located in Ohio, has been working to commercialize their Kinesia and Kinesia Home View medical technology platforms since 2003. The company serves the research, education, and medical communities, and seeks to help diverse populations improve their access to medical technologies to positively impact their quality of life.
For more information, go to www.glneurotech.com or email Amelia Earhart, Marketing Manager at aaearhart@GLNeuroTech.com or call (216) 446-2431 or mobile (619-808-8637. To find more information on Kinesia go to www.glneurotech.com/Kinesia and for Kinesia Home View, go to www.glneurotech.com/Kinesia-HomeView.
